131 related articles for article (PubMed ID: 2760667)
1. Prothrombin time ratio and other factors associated with bleeding in patients treated with warfarin.
Petitti DB; Strom BL; Melmon KL
J Clin Epidemiol; 1989; 42(8):759-64. PubMed ID: 2760667
[TBL] [Abstract][Full Text] [Related]
2. Duration of warfarin anticoagulant therapy and the probabilities of recurrent thromboembolism and hemorrhage.
Petitti DB; Strom BL; Melmon KL
Am J Med; 1986 Aug; 81(2):255-9. PubMed ID: 3740082
[TBL] [Abstract][Full Text] [Related]
3. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.
Couturaud F; Sanchez O; Pernod G; Mismetti P; Jego P; Duhamel E; Provost K; dit Sollier CB; Presles E; Castellant P; Parent F; Salaun PY; Bressollette L; Nonent M; Lorillon P; Girard P; Lacut K; Guégan M; Bosson JL; Laporte S; Leroyer C; Décousus H; Meyer G; Mottier D;
JAMA; 2015 Jul; 314(1):31-40. PubMed ID: 26151264
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation clinics and the monitoring of anticoagulant therapy.
Charney R; Leddomado E; Rose DN; Fuster V
Int J Cardiol; 1988 Feb; 18(2):197-206. PubMed ID: 3125115
[TBL] [Abstract][Full Text] [Related]
5. Bleeding in outpatients treated with warfarin: relation to the prothrombin time and important remediable lesions.
Landefeld CS; Rosenblatt MW; Goldman L
Am J Med; 1989 Aug; 87(2):153-9. PubMed ID: 2757055
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group.
Fihn SD; McDonell M; Martin D; Henikoff J; Vermes D; Kent D; White RH
Ann Intern Med; 1993 Apr; 118(7):511-20. PubMed ID: 8280198
[TBL] [Abstract][Full Text] [Related]
7. Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.
Raskob G; Ageno W; Cohen AT; Brekelmans MP; Grosso MA; Segers A; Meyer G; Verhamme P; Wells PS; Lin M; Winters SM; Weitz JI; Büller HR
Lancet Haematol; 2016 May; 3(5):e228-36. PubMed ID: 27132697
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation. Current approach to heparin and warfarin therapy.
Painter TD
Postgrad Med; 1983 Sep; 74(3):341-5, 348, 350. PubMed ID: 6889207
[TBL] [Abstract][Full Text] [Related]
9. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial.
Beyth RJ; Quinn L; Landefeld CS
Ann Intern Med; 2000 Nov; 133(9):687-95. PubMed ID: 11074901
[TBL] [Abstract][Full Text] [Related]
10. The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics.
Fihn SD; Callahan CM; Martin DC; McDonell MB; Henikoff JG; White RH
Ann Intern Med; 1996 Jun; 124(11):970-9. PubMed ID: 8624064
[TBL] [Abstract][Full Text] [Related]
11. Current concepts of warfarin therapy.
Peterson CE; Kwaan HC
Arch Intern Med; 1986 Mar; 146(3):581-4. PubMed ID: 3513725
[TBL] [Abstract][Full Text] [Related]
12. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.
Schulman S; Granqvist S; Holmström M; Carlsson A; Lindmarker P; Nicol P; Eklund SG; Nordlander S; Lärfars G; Leijd B; Linder O; Loogna E
N Engl J Med; 1997 Feb; 336(6):393-8. PubMed ID: 9010144
[TBL] [Abstract][Full Text] [Related]
13. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.
Wells PS; Forgie MA; Simms M; Greene A; Touchie D; Lewis G; Anderson J; Rodger MA
Arch Intern Med; 2003 Apr; 163(8):917-20. PubMed ID: 12719200
[TBL] [Abstract][Full Text] [Related]
14. Routine use of adjusted low-dose warfarin to prevent venous thromboembolism after total hip replacement.
Paiement GD; Wessinger SJ; Hughes R; Harris WH
J Bone Joint Surg Am; 1993 Jun; 75(6):893-8. PubMed ID: 8314829
[TBL] [Abstract][Full Text] [Related]
15. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
[TBL] [Abstract][Full Text] [Related]
16. Extended oral anticoagulant therapy after a first episode of pulmonary embolism.
Agnelli G; Prandoni P; Becattini C; Silingardi M; Taliani MR; Miccio M; Imberti D; Poggio R; Ageno W; Pogliani E; Porro F; Zonzin P;
Ann Intern Med; 2003 Jul; 139(1):19-25. PubMed ID: 12834314
[TBL] [Abstract][Full Text] [Related]
17. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis.
Hull R; Delmore T; Genton E; Hirsh J; Gent M; Sackett D; McLoughlin D; Armstrong P
N Engl J Med; 1979 Oct; 301(16):855-8. PubMed ID: 384248
[TBL] [Abstract][Full Text] [Related]
18. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
Kearon C; Gent M; Hirsh J; Weitz J; Kovacs MJ; Anderson DR; Turpie AG; Green D; Ginsberg JS; Wells P; MacKinnon B; Julian JA
N Engl J Med; 1999 Mar; 340(12):901-7. PubMed ID: 10089183
[TBL] [Abstract][Full Text] [Related]
19. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.
Gulløv AL; Koefoed BG; Petersen P
Arch Intern Med; 1999 Jun; 159(12):1322-8. PubMed ID: 10386508
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.
Hylek EM; Chang YC; Skates SJ; Hughes RA; Singer DE
Arch Intern Med; 2000 Jun; 160(11):1612-7. PubMed ID: 10847254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
